According to a research report published by Spherical Insights & Consulting, the Global Preeclampsia Diagnostics Market Size Expected to Grow from USD 1.08 Billion in 2023 to USD 1.39 Billion by 2033, at a CAGR of 2.56% during the forecast period 2023-2033.

Get a Sample PDF Brochure: https://www.sphericalinsights.com/request-sample/5097

Preeclampsia, also known as toxemia, is a rapidly progressing illness characterized by elevated blood pressure and a high protein content in the urine of pregnant women. In both industrialized and developing nations, it is one of the pregnancy-related hypertension conditions that is accelerating the rates of maternal and perinatal morbidity and mortality among women. To help doctors diagnose and treat preeclampsia in expectant patients, a variety of tests and instruments are employed in preeclampsia diagnostics. These diagnostic methods aid in the early detection, tracking, and assessment of the severity of the issue. Identification testing for preeclampsia will help reduce maternal and neonatal mortality. Preeclampsia is now more widely known thanks to recent initiatives by patient advocacy organizations and welfare associations. Considering the significant unmet need for preeclampsia diagnosis, this remains an essential element in providing profitable development opportunities for the production of innovative tests. Increased demand for early screening is anticipated to boost the market’s growth during the forecast period as a result of expanding awareness among healthcare professionals and pregnant women, as well as growing rates of the disease brought on by the adoption of unhealthy lifestyles. The market for preeclampsia diagnostics is expected to rise as a result of the growing research and development of innovative tests to find biomarkers. However, one elevated blood pressure reading is not enough to diagnose preeclampsia in pregnant women. Despite its increasing incidence, many expectant mothers are still unaware of what “preeclampsia” is and the dangers it poses.

Buy Now Full Report: https://www.sphericalinsights.com/checkout/5097

Browse key industry insights spread across 220 pages with 105 Market data tables and figures & charts from the report on the Global Preeclampsia Diagnostics Market Size, Share, and COVID-19 Impact Analysis, By Test Type (Blood Tests and Urine Analysis), By Product (Instruments and Consumables), By End-user (Hospitals, Specialty Clinics, Diagnostic Centers, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033

The blood tests segment dominates the market with the largest market share through the forecast period.

Based on the test type, the global preeclampsia diagnostics market is categorized into blood tests and urine analysis. Among these, the blood tests segment dominates the market with the largest market share through the forecast period. Blood tests that use markers such as placental growth factor and soluble FMS-like tyrosine kinase-1 can reliably detect conditions linked to pregnancy-induced hypertension. Additionally, by facilitating remote laboratory testing and centralized analysis, blood-based diagnostics improve diagnostic uniformity across different healthcare facilities. Blood testing technology advancements are bringing down costs while enhancing detection capabilities.

The consumables segment is anticipated to grow at the fastest CAGR growth through the forecast period.

Based on the product type, the global preeclampsia diagnostics market is categorized into instruments and consumables. Among these, the consumables segment is anticipated to grow at the fastest CAGR growth through the forecast period. Consumables such as reagents, kits, and other disposable items are necessary for all preeclampsia diagnostic tests. Furthermore, because of the practical limitations of reusable instruments, single-use consumables are often required for consistent and hygienic testing. Reagent vendors and instrument manufacturers can also benefit from consistent income streams because these products are consumable.

The hospitals segment accounted for the largest revenue share through the forecast period.

Based on the end-user, the global preeclampsia diagnostics market is categorized into hospitals, specialty clinics, diagnostic centers, and others. Among these, the hospitals segment accounted for the largest revenue share throughout the forecast period. The segmental growth can be attributed to the rise in in-hospital visits from patients with toxicemia. An increasing number of hospitals in developing countries with better healthcare infrastructures and increased hospitalization rates are also expected to fuel segmental expansion.

Inquire Before Buying This Research Report: https://www.sphericalinsights.com/inquiry-before-buying/5097  

North America is estimated to hold the largest share of the global preeclampsia diagnostics market over the predicted timeframe.

North America is anticipated to hold the largest share of the global preeclampsia diagnostics market over the predicted timeframe. The region’s advanced healthcare system, robust R&D capabilities, and high levels of maternal health awareness are major factors contributing to its dominant position. Advanced diagnostic technologies are also more readily adopted in North America when academic institutions, healthcare providers, and corporate leaders have strong ties.

Asia Pacific is expected to grow at the fastest CAGR growth of the global preeclampsia diagnostics market during the forecast period. This expansion is a result of several factors, including rising healthcare spending, increased awareness of maternal health, and the growth of healthcare infrastructure in the countries of the region.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the global preeclampsia diagnostics market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market. Major vendors in the global preeclampsia diagnostic market are F. Hoffmann-La Roche Ltd., PerkinElmer Inc., Abbott Laboratories, DRG INSTRUMENTS GMBH, Thermo Fisher Scientific Inc., Diabetomics, Inc., Roche Diagnostic, Metabolomic Diagnostics Ltd., Sera Prognostics, The Progenix Group, Siemens Healthineers AG, Bayer AG, Quidel Corporation, Brahms GmbH, and others.

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Key Market Development

• In January 2024, the laboratory services provider Labcorp launched a blood test for the assessment and management of severe preeclampsia risk that has been approved by the USFDA. One of TIME Magazine’s Best Inventions of 2023, the test was created by Thermo Fisher Scientific and detects two biomarkers linked to preeclampsia.
• In July 2023, The USFDA approved a blood test developed by pharmaceutical and biotechnology company Thermo Fisher Scientific that accurately predicts preeclampsia in two weeks 96% of the time. Highly esteemed by experts such as Dr. Douglas Woelkers of the University of California, San Diego, it signifies a noteworthy advancement in the identification of preeclampsia.

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the global industrial FDM 3D printer market based on the below-mentioned segments:

Global Preeclampsia Diagnostics Market, By Test Type

• Blood Tests
• Urine Analysis

Global Preeclampsia Diagnostics Market, By Product Type

• Instruments
• Consumables

Global Preeclampsia Diagnostics Market, By End User

• Hospitals
• Specialty Clinics
• Diagnostic Centers
• Others

Global Preeclampsia Diagnostics Market, By Regional Analysis

• North America

• • US
  • Canada
  • Mexico

• Europe

• • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe

• Asia Pacific

• • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific

• South America

• • Brazil
  • Argentina
  • Rest of South America

• Middle East & Africa

• • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa

Browse Related Keys:

Global Life Science Products Market Size, Share, and COVID-19 Impact Analysis, By Product Type (Reagents, Instruments, Consumables and Services), By Application (Drug Discovery & Development, Basic Research, Applied Research and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 – 2035

Global Life Science Microscopy Devices Market Size, Share, and COVID-19 Impact Analysis, By Product Type (Optical Microscopes, Electron Microscopes, Scanning Probe Microscope, Confocal Microscopes and Fluorescence Microscopes), By End User (Research Laboratories and Institutes, Forensic and Diagnostic Laboratories, and Pharmaceutical and Biotechnology Companies), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033

Global E. coli Testing Market Size, Share, and COVID-19 Impact Analysis, By Product (Instruments and Consumables), By Test Type (Clinical Test and Environmental Test), By End-User (Diagnostic Laboratories, Hospitals, Clinics, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033

Global Virtual Clinical Trials Market Size, Share, and COVID-19 Impact Analysis, By Study Design (Interventional, Observational, and Expanded Access), By Indication (Oncology and Cardiovascular Disease), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033

About the Spherical Insights & Consulting

Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.

Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company’s mission is to work with businesses to achieve business objectives and maintain strategic improvements.

CONTACT US:

For More Information on Your Target Market, Please Contact Us Below:    

Phone: +1 303 800 4326 (the U.S.)

Phone: +91 90289 24100 (APAC)

Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com

Contact Us: https://www.sphericalinsights.com/contact-us

Follow Us: LinkedIn | Facebook | Twitter